6.49
6.49 (0%)
As of Feb 14, 2025
Aldeyra Therapeutics, Inc. [ALDX]
Source:
Company Overview
Aldeyra Therapeutics, Inc. is a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases. Our approach is to develop pharmaceuticals that modulate protein systems, instead of directly inhibiting or activating single protein targets, with the goal of optimizing multiple pathways at once while minimizing toxicity.
Country | United States |
Headquarters | lexington, massachusetts |
Phone Number | 781-761-4904 |
Industry | manufacturing |
CEO | Todd C. Brady, M.D., Ph.D. |
Website | www.aldeyra.com |